Novel peptide for coagulation disorders Project Overview

Product: New Peptide drug to reduce thrombosis rate without increased risk of bleeding

Need: Multiple conditions necessitate anti-thrombosis treatment (arrhythmias for example), however current drugs carry the risk of increased rates of bleeding

Status: Animal studies

IP: National Phase

Team
Dr. Yona Nadir,
Prof. Benjamin Brenner,
Department of Hematology, Rambam HCC